Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019)

Amneal Pharmaceuticals (AMRX) recorded quarterly Current Taxes of $8.7 million in Q4 2019, up 653.15% quarter-over-quarter from $1.2 million in Q4 2018, and up 653.15% on a YoY basis from $1.2 million in Q4 2018.

Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019) Analysis & Trends

Amneal Pharmaceuticals' Current Taxes history runs 2 years deep, the most recent figure standing at $8.7 million for Q4 2019.

  • In Q4 2019, Current Taxes rose 653.15% year-over-year to $8.7 million; the TTM figure through Dec 2019 stood at $8.7 million (up 653.15% YoY), while the FY2019 annual figure was $8.7 million, up 653.15% from the prior year.
  • Current Taxes was $8.7 million for Q4 2019 at Amneal Pharmaceuticals, up from $1.2 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $8.7 million in Q4 2019 to a low of $1.2 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 211.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 4.61 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.15 Mn
10 Amneal Pharmaceuticals 4.66 Bn 4.65 Bn 320.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 8.73 Mn
Dec 31, 2018 1.16 Mn